Role of glutathione in dimethylarsinic acid-induced apoptosis

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 354-365

  Sakurai, Teruaki ^a   Ochiai, Masayuki ^a   Kojima, Chikara ^a   Ohta, Takami ^a   Sakurai, Masumi H ^b   Takada, Naoko O ^b   Qu, Wei ^c   Waalkes, Michael P ^c   Fujiwara, Kitao ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b AZABU UNIVERSITY   (Japan)

^c Lab of Comparative Carcinogenesis   (United States)

Author keywords

5,5 dithiobis (2 nitrobenzoic acid); 5,5 dimethyl 1 pyrroline N oxide; Apoptosis; Arsenic; BSO; Caspase; dimethylarsinic acid; Dimethylarsinic acid; DMAs V; DMPO; DTNB; Glutathione; GSH; GSSG; L Buthionine S,R sulfoximine; reduced glutathione

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; BUTHIONINE SULFOXIMINE; CACODYLIC ACID; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CASPASE INHIBITOR; ENZYME INHIBITOR; GLUTATHIONE; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CELL LINE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LETHALITY; LIVER CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; RAT; REVIEW; TIME;

ANIMALS; APOPTOSIS; BUTHIONINE SULFOXIMINE; CACODYLIC ACID; CASPASES; CELL LINE; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; HERBICIDES; HUMANS; LIVER; RATS; RATS, INBRED F344;

MAMMALIA; RODENTIA;

EID: 3242794374     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.015     Document Type: Review

References (43)

1. Akao Y., Nakagawa Y., Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455:1999;59-62
2. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health. 48:1980;71-79
3. Chen G.Q., Shi X.G., Xiong S.M., Zhu J., Cai X., Han Z.G., Ni J.H., Shi G.Y., Jia P.M., Liu M.M., He K.L., Niu C., Ma J., Zhang P., Zhang T.D., Paul P., Naoe T., Kitamura K., Miller W., Waxman S., Wang Z.Y., de The H., Chen S.J., Chen Z. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood. 89:1997;3345-3353
4. D'Agostini F., Balansky R.M., Izzotti A., Lubet R.A., Kelloff G.J., De Flora S. Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis. 22:2001;375-380
5. Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem.-Biol. Interact. 90:1994;139-155
6. Domon O.E., McGarrity L.J., Bishop M., Yoshioka M., Chen J.J., Morris S.M. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK (+/-) human lymphoblastoid cells. Mutat. Res. 474:2001;129-137
7. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77
8. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226
9. Huang H., Huang C.F., Wu D.R., Jinn C.M., Jan K.Y. Glutathione as a cellular defense against arsenite toxicity in cultured Chinese hamster ovary cells. Toxicology. 79:1993;195-204
10. IARC International agency for research on cancer monographs on the evaluation of the carcinogenic risks to humans: supplement 7. Overall Evaluations Carcinogenicity: An Updating of IARC Monographs. vol. 1-42:1987;100-106 IARC Scientific Publications, Lyon, France
11. Idoine J.B., Elliott J.M., Wilson M.J., Weisburger E.K. Rat liver cells in culture: effect of storage, long-term culture, and transformation on some enzyme levels. In Vitro. 12:1976;541-553
12. Kaise T., Yamauchi H., Horiguchi Y., Tani T., Watanabe S., Hirayama T., Fukui S. A comparative study on acute toxicity of methylarsonic acid, dimethylarsinic acid and trimethylarsine oxide in mice. Appl. Organomet. Chem. 3:1989;273-277
13. Kondo H., Yonezawa Y. Fetal-adult phenotype transition, in terms of the serum dependency and growth factor requirements, of human skin fibroblast migration. Exp. Cell Res. 220:1995;501-504
14. Lazo J.S., Kondo Y., Dellapiazza D., Michalska A.E., Choo K.H.A., Pitt B.R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem. 270:1995;5506-5510
15. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72:2000;5172-5177
16. Lee T.C., Wei M.L., Chang W.J., Ho I.C., Lo J.F., Jan K.Y., Huang H. Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells. In Vitro Cell. Dev. Biol. 25:1989;442-448
17. Li W., Chou I.N. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol. Appl. Pharmacol. 114:1992;132-139
18. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378
19. Manning F.C.R., Patierno S.R. Apoptosis: inhibitor or instigator of carcinogenesis? Cancer Invest. 14:1996;455-465
20. NRC, 1999. Arsenic in the Drinking Water. National Research Council, National Academy Press, Washington, DC.
21. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L., Yuki K., Miyauchi T., Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in Inner Mongolia. Free Radical Biol. Med. 28:2000;1137-1142
22. Romach E.H., Zhao C.Q., Razo L.M.D., Cebrian M.E., Waalkes M.P. Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol. Sci. 54:2000;500-508
23. Sakurai T. Molecular mechanisms of dimethylarsinic acid-induced apoptosis. Biomed. Res. Trace Elem. 13:2002;167-176
24. Sakurai T. Biomethylation of arsenic is essentially detoxicating event. J. Health Sci. 49:2003;171-178
25. Sakurai T., Kaise T., Matsubara C. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 11:1998;273-283
26. Sakurai T., Qu W., Sakurai M.H., Waalkes M.P. A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis. Chem. Res. Toxicol. 15:2002;629-637
27. Scott N., Hatleid K.M., MacKenzie N.E., Carter D.E. Reactions of arsenic (III) and arsenic (V) species with glutathione. Chem. Res. Toxicol. 6:1993;102-106
28. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:1997;3344-3360
29. Shimizu M., Hochadel J.F., Fulmer A., Waalkes M.P. Effect of glutathione depletion and metallothionein gene expression an arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol. Sci. 45:1998;204-211
30. Styblo M., Delnomdedieu M., Thomas D.J. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem.-Biol. Interact. 99:1996;147-164
31. Styblo M., Vega L., Germolec D.R., Luster M.I., Razo L.M.D., Wang C., Cullen W.R., Thomas D.J. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 1999;311-323 Elsevier, New York, NY
32. Tezuka M., Hanioka K., Yamanaka K., Okada S. Gene damage induced in human alveolar type (L-132) cells by exposure to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 191:1993;1178-1183
33. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem.-Biol. Interact. 88:1993;89-114
34. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82(Pt. 1):1999;69-88
35. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133:1995;262-268
36. Waalkes M.P., Fox D.A., States C.J., Patierno S.R., McCabe M.J. Jr. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol. Sci. 56:2000;255-261
37. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 20:1999;1873-1876
38. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 23:2002;1387-1397
39. Wei Q., Bortner C.D., Sakurai T., Hobson M.J., Waalkes M.P. Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway. Caricinogenesis. 23:2002;151-159
40. Yamanaka K., Ohtsubo K., Hasegawa A., Hayashi H., Ohji H., Kanisawa M., Okada S. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis. 17:1996;767-770
41. Yamauchi H., Yamamura Y. Dynamic change of inorganic arsenic and methylarsenic compounds in human urine after oral intake as arsenic trioxide. Ind. Health. 17:1979;79-83
42. Yamauchi H., Yoshida T., Aikawa H., Sato T., Niwa M., Saito S., Aminaka M., Kayama F., Yoshida K. Study on the metabolism of arsenic acid fluoride in the chronic arsenic poisoning in Inner Mongolia, China. Toxicol. Sci. 48:1999;350
43. Zakharyan R.A., Ayala-Fierro F., Cullen W.R., Carter D.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: VII. Monomethylarsonous acid (MMAIII) is the substrate for MAA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15